{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T21:17:07Z","timestamp":1767907027573,"version":"3.49.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.vaccine.2010.05.069","type":"journal-article","created":{"date-parts":[[2010,6,11]],"date-time":"2010-06-11T06:42:53Z","timestamp":1276238573000},"page":"5197-5202","source":"Crossref","is-referenced-by-count":59,"title":["Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO\u00ae, IC51"],"prefix":"10.1016","volume":"28","author":[{"given":"Katrin","family":"Dubischar-Kastner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Eder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Buerger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Gartner-Woelfl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Kaltenboeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Schuller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erich","family":"Tauber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Klade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.05.069_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1708-8305.2009.00333.x","article-title":"Japanese encephalitis in travelers: review of cases and seasonal risk","volume":"16","author":"Buhl","year":"2009","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2010.05.069_bib2","unstructured":"Japanese Encephalitis; 2009 (Accessed October 2009, at http:\/\/www.cdc.gov\/ncidod\/dvbid\/jencephalitis\/facts.htm)."},{"key":"10.1016\/j.vaccine.2010.05.069_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/oxfordjournals.epirev.a036087","article-title":"The epidemiology of Japanese encephalitis: prospects for prevention","volume":"14","author":"Vaughn","year":"1992","journal-title":"Epidem Rev"},{"key":"10.1016\/j.vaccine.2010.05.069_bib4","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJMp058263","article-title":"Control of Japanese encephalitis-within our grasp?","volume":"355","author":"Solomon","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2010.05.069_bib5","first-page":"1","article-title":"Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Fischer","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2010.05.069_bib6","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(07)61780-2","article-title":"Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial","volume":"370","author":"Tauber","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.05.069_bib7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/590116","article-title":"Randomized, double-blind, placebo controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine","volume":"198","author":"Tauber","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.05.069_bib8","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1016\/j.vaccine.2008.05.081","article-title":"Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51. Six and 12 month results of a multicenter follow-up phase 3 study","volume":"26","author":"Schuller","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.05.069_bib9","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.vaccine.2008.12.062","article-title":"Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: a randomized, observer-blind, controlled phase 3 study","volume":"27","author":"Schuller","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.05.069_bib10","series-title":"Statistics with confidence","author":"Altman","year":"2000"},{"key":"10.1016\/j.vaccine.2010.05.069_bib11","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1016\/j.vaccine.2008.08.056","article-title":"Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51","volume":"26","author":"Schuller","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.05.069_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1467-842X.2005.tb00747.x","article-title":"An assessment of the interval between doses of Japanese encephalitis vaccine in the Torres Strait","volume":"29","author":"Hanna","year":"2005","journal-title":"Aust N Z J Public Health"},{"key":"10.1016\/j.vaccine.2010.05.069_bib13","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1016\/j.vaccine.2003.08.005","article-title":"Kinetics of the immune response after primary and booster immunization against tick-borne encephalitis (TBE) in adults using the rapid immunization schedule","volume":"21","author":"Zent","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.05.069_bib14","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1016\/j.vaccine.2006.12.046","article-title":"A phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis","volume":"25","author":"Lyons","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.05.069_bib15","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/infdis\/160.5.766","article-title":"Comparison of three different vaccination schedules","volume":"160","author":"Jilg","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.05.069_bib16","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.vaccine.2004.01.041","article-title":"Persistence of protective immunity following vaccination against tick-borne encephalitis\u2014longer than expected?","volume":"22","author":"Rendi-Wagner","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.05.069_bib17","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1016\/j.vaccine.2006.12.046","article-title":"A phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis","volume":"25","author":"Lyons","year":"2007","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10007905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10007905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T21:40:36Z","timestamp":1559166036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10007905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":17,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0264410X10007905"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.05.069","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}